SCHEMBL31528335

SCHEMBL31528335

COCc1noc(CSc2nc(C)cc(N)n2)n1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.50
▸ HTT P42858 3/20 0.50
▸ NPC1 O15118 2/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ LMNA P02545 2/20 0.50
▸ ALDH1A1 P00352 4/20 0.36
▸ ATM Q13315 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ HPGD P15428 1/20 0.34
▸ MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27218748 1.00 RAB9A (0.50) RAB9AHTTNPC1SMN1; SMN2LMNA
SCHEMBL27218782 0.87 RAB9A (0.47) RAB9AHTTNPC1SMN1; SMN2LMNA
SCHEMBL31494455 0.85 RAB9A (0.48) RAB9AHTTNPC1SMN1; SMN2LMNA
SCHEMBL27218817 0.82 RAB9A (0.50) RAB9AHTTNPC1SMN1; SMN2LMNA
SCHEMBL27218673 0.82 RAB9A (0.46) RAB9AHTTNPC1SMN1; SMN2LMNA
SCHEMBL27218708 0.81 RAB9A (0.49) RAB9AHTTNPC1SMN1; SMN2LMNA
SCHEMBL27218777 0.78 RAB9A (0.48) RAB9AHTTNPC1SMN1; SMN2LMNA
SCHEMBL31494410 0.77 RAB9A (0.52) RAB9AHTTNPC1SMN1; SMN2LMNA
SCHEMBL27218874 0.75 HTT (0.69) RAB9AHTTNPC1SMN1; SMN2LMNA
SCHEMBL27218745 0.75 RAB9A (0.50) RAB9AHTTNPC1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3956323-B1 OXAZOLE AND OXADIAZOLE DERIVATIVES USEFUL AS AGONISTS OF FREE FATTY ACID RECEPTOR 1 Halo Therapeutics Ltd (GB) 2025-03-05 — — EP disclosed
Send feedback